5/8/2024, 8:22:02 pm

Biocon gets US FDA report after Vizag facility scan

Biocon Ltd received an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) from the US FDA for its API facility in Visakhapatnam, after a GMP inspection from June 17-21, 2024. The company reiterated its commitment to maintaining high standards of quality, safety, and efficacy.